SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales is pegged at Rs. 45481.10 millions for the September 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 51224.70 millions during the year-ago period.A big decline of -32.70% was reported for the quarter ended September 2025 to Rs. 5642.20  millions from Rs. 8383.70 millions of corresponding previous quarter.A decline of 12563.80 millions was observed in the OP in the quarter ended September 2025 from 14270.80 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 45481.10 51224.70 -11.21 101500.70 96205.40 5.50 230033.30 202751.70 13.46
Other Income 5544.10 2237.80 147.75 8476.20 3065.20 176.53 6239.70 4657.60 33.97
PBIDT 12563.80 14270.80 -11.96 32512.20 22708.90 43.17 71620.50 60533.70 18.32
Interest 2483.30 2590.40 -4.13 4716.20 4751.20 -0.74 8932.10 7840.80 13.92
PBDT 10080.50 11680.40 -13.70 24919.60 17957.70 38.77 62688.40 50502.70 24.13
Depreciation 3363.00 2972.30 13.14 6353.30 6670.40 -4.75 12382.70 16006.20 -22.64
PBT 6717.50 8708.10 -22.86 18566.30 11287.30 64.49 50305.70 34496.50 45.83
TAX 1075.30 324.40 231.47 5388.80 525.40 925.66 7479.50 5914.70 26.46
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 5642.20 8383.70 -32.70 13177.50 10761.90 22.45 42826.20 28581.80 49.84
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 27.62 27.86 -0.84 32.03 23.60 35.70 31.13 29.86 4.28

Sun Pharma Inds. Share Price

1668.00 -7.20 (-0.43%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×